Speaking as a 53 yr old prostate cancer survivor, I for one am overjoyed that Stanford researcher Thomas Stramey, MD is not MY personal physician. By Stramey's current standards I would not even have been a candidate for the biopsy which showed moderately agressive cancer in all 11 of 11 different prostate sites sampled. Just let it grow, I guess, till I'm off with Dan Fogelburg.

I was beginning to wonder which insurance company might have,just perhaps, (in the all- holy name of cost containment) put the good Dr. in its pocket (my little episode ran my insurance company roughly $28,000),
when I ran across this site Recent Discovery Contracts which dispelled any notions of that sort . Please note the last sentance of the 1st paragraph.

It seems the good Dr. has a new test for prostate cancer in the works, one in which he just happens to have a joint owenership of the " world-wide exclusive license for commercialization".

What a lovely coincidence for him. Just as he becomes the joint owner of a new test, he discovers the PSA-era is over.